GB2478072B - Anti-tumoural effects of cannabinoid combinations - Google Patents

Anti-tumoural effects of cannabinoid combinations

Info

Publication number
GB2478072B
GB2478072B GB1105991.2A GB201105991A GB2478072B GB 2478072 B GB2478072 B GB 2478072B GB 201105991 A GB201105991 A GB 201105991A GB 2478072 B GB2478072 B GB 2478072B
Authority
GB
United Kingdom
Prior art keywords
anti
cannabinoid combinations
tumoural
effects
tumoural effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1105991.2A
Other versions
GB2478072A (en
GB201105991D0 (en
Inventor
Guillermo Velasco Diez
Manuel Guzman Pastor
Mar Lorente
Sofia Torres
Fatima Rodriguez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GW Pharma Ltd
Otsuka Pharmaceutical Co Ltd
Original Assignee
GW Pharma Ltd
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GW Pharma Ltd, Otsuka Pharmaceutical Co Ltd filed Critical GW Pharma Ltd
Priority to GB0810195.8A priority Critical patent/GB2471987B/en
Priority to GB1105991.2A priority patent/GB2478072B/en
Publication of GB201105991D0 publication Critical patent/GB201105991D0/en
Publication of GB2478072A publication Critical patent/GB2478072A/en
Application granted granted Critical
Publication of GB2478072B publication Critical patent/GB2478072B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
GB1105991.2A 2008-06-04 2008-06-04 Anti-tumoural effects of cannabinoid combinations Active GB2478072B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0810195.8A GB2471987B (en) 2008-06-04 2008-06-04 Anti-tumoural effects of cannabinoid combinations
GB1105991.2A GB2478072B (en) 2008-06-04 2008-06-04 Anti-tumoural effects of cannabinoid combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1105991.2A GB2478072B (en) 2008-06-04 2008-06-04 Anti-tumoural effects of cannabinoid combinations

Publications (3)

Publication Number Publication Date
GB201105991D0 GB201105991D0 (en) 2011-05-18
GB2478072A GB2478072A (en) 2011-08-24
GB2478072B true GB2478072B (en) 2012-12-26

Family

ID=44072184

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1105991.2A Active GB2478072B (en) 2008-06-04 2008-06-04 Anti-tumoural effects of cannabinoid combinations

Country Status (1)

Country Link
GB (1) GB2478072B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125859B2 (en) 2010-03-30 2015-09-08 Gw Pharma Limited Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
US9474726B2 (en) 2014-06-17 2016-10-25 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US9522123B2 (en) 2009-07-03 2016-12-20 Gw Pharma Limited Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
US10092525B2 (en) 2014-10-14 2018-10-09 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10729665B2 (en) 2011-09-29 2020-08-04 Gw Pharma Limited Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2548873A (en) 2016-03-31 2017-10-04 Gw Res Ltd Use of cannabinoids in treatment of epilepsy

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058445A1 (en) * 2000-02-11 2001-08-16 Universidad Complutense De Madrid Therapy with cannabinoids in the treatment of cerebral tumor
US20040039048A1 (en) * 2000-02-11 2004-02-26 Manuel Guzman Pastor Therapy with cannabinoid compounds for the treatment of brain tumors
US20080057117A1 (en) * 2002-02-15 2008-03-06 Forschungs Institut Miscia Verenfur Krebsforschung Pharmaceutical composition made up of cannibus extracts
WO2008144475A1 (en) * 2007-05-17 2008-11-27 California Pacific Medical Center Methods and compositions for treating cancer

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058445A1 (en) * 2000-02-11 2001-08-16 Universidad Complutense De Madrid Therapy with cannabinoids in the treatment of cerebral tumor
US20040039048A1 (en) * 2000-02-11 2004-02-26 Manuel Guzman Pastor Therapy with cannabinoid compounds for the treatment of brain tumors
US20080057117A1 (en) * 2002-02-15 2008-03-06 Forschungs Institut Miscia Verenfur Krebsforschung Pharmaceutical composition made up of cannibus extracts
WO2008144475A1 (en) * 2007-05-17 2008-11-27 California Pacific Medical Center Methods and compositions for treating cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Medical Hypotheses (2006), Vol. 66, pp234-246 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9522123B2 (en) 2009-07-03 2016-12-20 Gw Pharma Limited Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
US9125859B2 (en) 2010-03-30 2015-09-08 Gw Pharma Limited Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
US10729665B2 (en) 2011-09-29 2020-08-04 Gw Pharma Limited Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US9474726B2 (en) 2014-06-17 2016-10-25 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10092525B2 (en) 2014-10-14 2018-10-09 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10111840B2 (en) 2014-10-14 2018-10-30 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10137095B2 (en) 2014-10-14 2018-11-27 Gw Pharma Limited Use of cannabinoids in the treatment of epilepsy
US10709673B2 (en) 2014-10-14 2020-07-14 GW Research Limited Use of cannabinoids in the treatment of epilepsy
US10709674B2 (en) 2014-10-14 2020-07-14 GW Research Limited Use of cannabinoids in the treatment of epilepsy

Also Published As

Publication number Publication date
GB201105991D0 (en) 2011-05-18
GB2478072A (en) 2011-08-24

Similar Documents

Publication Publication Date Title
HRP20130047T1 (en) Substituted pyrrolidine-2-carboxamides
HK1159157A1 (en) Organ-on-a-chip-device
HK1152940A1 (en) Novel substituted pyridin-2-ones and pyridazin-3-ones -2--3-
ZA201006252B (en) Preparation of lenalidomide
IL209916D0 (en) Mucleoside cyclicphosphates
HK1161239A1 (en) Pyridine-3-carboxyamide derivative -3-
HK1155444A1 (en) Imidazopyridin-2-one derivatives -2-
PL2918172T3 (en) Połączenia środków kontroli biologicznej i fungicydów
EP2332387A4 (en) Inter-threading indications of different types of communication
DK200970290A (en) Gaskompressionssystem
GB0809631D0 (en) Zonesense
EP2248460A4 (en) Stereomicroscope
EP2291078A4 (en) Oxazolobenzimidazole derivatives
EP2331543A4 (en) 3-deazaneplanocin derivatives
GB0818498D0 (en) Provision of inserts
AU322032S (en) Headset
EP2279532A4 (en) Oxazolobenzimidazole derivatives
PL2318599T3 (en) Zawór napowietrzający
ZA201007734B (en) Separation-apparatus
HRP20140650T1 (en) Hydroxymethylcyclohexylamines
EP2275418A4 (en) Chromene compound
HK1156306A1 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases hif--4-
EP2302028A4 (en) Sequencer
IL210343D0 (en) 5 - alkynyl - pyrimidines
GB2459968B (en) Efficiency-based determination of operational characteristics